Stanton, Christopher <br/><br/>
Greater symptom duration predicts response to immunomodulatory therapy in dilated cardiomyopathy.  [electronic resource] 

 -  International journal of cardiology  Aug 2008 
 - 38-41 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1874-1754 
<br/><br/><label>Standard No.: </label>10.1016/j.ijcard.2007.05.016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cardiomyopathy, Dilated--drug therapy<br/>Glucocorticoids--therapeutic use<br/>Humans<br/>Immunoglobulins, Intravenous--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Inflammation--physiopathology<br/>Logistic Models<br/>Randomized Controlled Trials as Topic<br/>Statistics, Nonparametric<br/>Stroke Volume